Oragenics (OGEN) EBITDA Margin Growth (1y) (2011 - 2023)
Oragenics (OGEN) EBITDA Margin Growth (1y) (2011 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.52 Bn | 132.67 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.55 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 65.31 Bn | 60.13 Bn | 1.37 Bn | 1,135.00 |
| 4 | Moderna | 61.77 Bn | 56.64 Bn | 52.00 Mn | 7,666.00 |
| 5 | BeOne Medicines | 42.26 Bn | 37.16 Bn | 1.53 Bn | 1,238.00 |
| 6 | Alnylam Pharmaceuticals | 31.19 Bn | 27.88 Bn | 992.69 Mn | 2,002.00 |
| 7 | BioNTech SE | 28.71 Bn | 10.31 Bn | 668.28 Mn | -3,558.00 |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 29,091.00 |
| 9 | Royalty Pharma | 27.35 Bn | 26.52 Bn | - | -1,651.00 |
| 10 | Oragenics | 2.39 Mn | 2.39 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -2.35 Mn |
| Jun 30, 2023 | -1.18 Mn |
| Mar 31, 2023 | 1.35 Mn |
| Dec 31, 2014 | 14,898.00 |
| Sep 30, 2014 | 316,569.00 |
| Jun 30, 2014 | 61,139.00 |
| Mar 31, 2014 | 21,599.00 |
| Dec 31, 2013 | -24,514.00 |
| Sep 30, 2013 | -288,710.00 |
| Jun 30, 2013 | 144,110.00 |
| Mar 31, 2013 | -59,552.00 |
| Dec 31, 2012 | -396.00 |
| Sep 30, 2012 | -30,501.00 |
| Jun 30, 2012 | -201,583.00 |
| Mar 31, 2012 | 4,441.00 |
| Dec 31, 2011 | 30,506.00 |
| Sep 30, 2011 | 2,470.00 |
| Jun 30, 2011 | -359.00 |